Home > Financial Ratios > SOLARA ACTIVE PHARMA SCIENCES

SOLARA ACTIVE PHARMA SCIENCES
Core EBITDA Margin

    Back to All Ratios
SOLARA ACTIVE PHARMA SCIENCES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SOLARA ACTIVE PHARMA SCIENCES
Please provide your vote to see the results

SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) -7.389.276.3123.8719.63

What is the latest Core EBITDA Margin ratio of SOLARA ACTIVE PHARMA SCIENCES ?

The latest Core EBITDA Margin ratio of SOLARA ACTIVE PHARMA SCIENCES is -7.38 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar2024-7.38
Mar20239.27
Mar20226.31
Mar202123.87
Mar202019.63

How is Core EBITDA Margin of SOLARA ACTIVE PHARMA SCIENCES Trending?

Years Core EBITDA Margin % Change
Mar2024 -7.38
Negative
Mar2023 9.27
46.91
Mar2022 6.31
-73.57
Mar2021 23.87
21.60
Mar2020 19.63 -

Other Financial Ratios of SOLARA ACTIVE PHARMA SCIENCES


Compare Core EBITDA Margin ratio of peers of SOLARA ACTIVE PHARMA SCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES ₹2,521.4 Cr 8.7% 6% 6.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,588.0 Cr -7.3% 1.1% 15.2% Stock Analytics
DIVIS LABORATORIES ₹157,711.0 Cr -3.5% 12.9% 53.4% Stock Analytics
CIPLA ₹122,115.0 Cr 0.1% 9.2% 6.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,589.0 Cr -1% 0.2% 19.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,746.6 Cr 3.1% 9.8% -7.6% Stock Analytics


SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES

8.7%

6%

6.1%

SENSEX

2%

9.4%

11.6%


You may also like the below Video Courses